FDA Approves Immunotherapy to Help Prevent Relapse of Melanoma
As of Wednesday, patients with operable stage III melanoma can now receive the immunotherapy drug ipilimumab (Yervoy®) as adjuvant therapy to help prevent recurrence of their cancer. The FDA based its approval on the…